1 – 10 of 25
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Targeting TUBG1 in RB1-negative tumors
2025) In FASEB journal : official publication of the Federation of American Societies for Experimental Biology 39(5).(
- Contribution to journal › Article
-
Mark
Mitochondrial proteome landscape unveils key insights into melanoma severity and treatment strategies
(
- Contribution to journal › Article
- 2024
-
Mark
Enhancing cell death in B-cell malignancies through targeted inhibition of Bcl-3
(
- Contribution to journal › Article
-
Mark
Identification of an osteopontin-derived peptide that binds neuropilin-1 and activates vascular repair responses and angiogenesis
(
- Contribution to journal › Article
- 2019
-
Mark
Physciosporin suppresses the proliferation, motility and tumourigenesis of colorectal cancer cells
(
- Contribution to journal › Article
-
Mark
Pharmacological inhibition of ABCC3 slows tumour progression in animal models of pancreatic cancer
(
- Contribution to journal › Article
- 2018
-
Mark
Targeted NUDT5 inhibitors block hormone signaling in breast cancer cells
(
- Contribution to journal › Article
-
Mark
Loss of cyclin-dependent kinase 1 impairs bone formation, but does not affect the bone-anabolic effects of parathyroid hormone
(
- Contribution to journal › Article
-
Mark
Potassium usnate, a water-soluble usnic acid salt, shows enhanced bioavailability and inhibits invasion and metastasis in colorectal cancer
(
- Contribution to journal › Article
-
Mark
Biocompatibility of two model elastin-like recombinamer-based hydrogels formed through physical or chemical cross-linking for various applications in tissue engineering and regenerative medicine
(
- Contribution to journal › Article